The Global Plant Tissue Culture Market size is expected to be worth around US$ 1.2 Billion by 2034, from US$ 0.5 Billion in 2024, growing at a CAGR of 9.2% during the forecast period from 2025 to 2034.

By 2025, the Plant Tissue Culture Market is evolving with increased adoption of molecular breeding and genetic transformation technologies. Tissue culture platforms are being used to develop climate-resilient maize, drought-tolerant rice, and disease-resistant vegetables through gene editing and somaclonal variation. R&D efforts are focusing on marker-assisted selection in vitro, speeding up trait stacking.

Contract research providers are partnering with seed companies to deliver scalable tissue culture pipelines—for doubled haploids, transgenics, and CRISPR-modified lines. Government funding in emerging markets is supporting local biotech hubs. These advances are ushering in a new era of precision agriculture, where tissue culture underpins rapid crop trait improvement.

Click here for more information: https://market.us/report/plant-tissue-culture-market/

Emerging Trends

1. Gene editing via CRISPR workflows, using tissue culture to regenerate edited plants.
2. Doubled haploid production for accelerated breeding cycles and homozygous lines.
3. Marker-assisted somaclonal variation screening within culture vessels.
4. Public-private partnerships for biotech pipeline scaling in emerging agricultural economies.

Use Cases

1. A seed developer creates drought-resistant maize by regenerating CRISPR-edited lines from cultured embryos.
2. A commercial breeder uses doubled haploid culture to advance rice in just two seasons instead of six.
3. A biotech contract lab screens for disease-resistant potato clones using in vitro PCR-based markers.
4. A government-funded tissue culture centre collaborates with seed companies to develop climate-smart vegetable varieties.